TREA

Demonstrated in vivo effect

Follow

Industry

  • CPC
  • C12N2760/18771
This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12NMICRO-ORGANISMS OR ENZYMES COMPOSITIONS THEREOF PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS MUTATION OR GENETIC ENGINEERING CULTURE MEDIA C12N2760/00ssRNA Viruses negative-sense

Current Industry

C12N2760/18771Demonstrated in vivo effect
Industries

Patents Grantslast 30 patents

  • Information Patent Grant

    Recombinant human parainfluenza virus type 1 expressing a chimeric...
    • Patent number 12,018,051
    • Issue date Jun 25, 2024
    • The USA, as represented by the Secretary, Department of Health and Human Serv...
    • Peter Collins
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Grant

    Recombinant human/bovine parainfluenza virus 1 (HPIV1) expressing a...
    • Patent number 11,591,372
    • Issue date Feb 28, 2023
    • The United States of America, as represented by the Secretary, Department of...
    • Peter Collins
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Grant

    Parainfluenza virus 5 based vaccines
    • Patent number 11,542,527
    • Issue date Jan 3, 2023
    • University of Georgia Research Foundation, Inc.
    • Biao He
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Parainfluenza virus 5 based vaccines
    • Patent number 10,752,916
    • Issue date Aug 25, 2020
    • University of Georgia Research Foundation, Inc.
    • Biao He
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Recombinant human/bovine parainfluenza virus 3 (B/HPIV3) expressing...
    • Patent number 10,654,898
    • Issue date May 19, 2020
    • The United States of America, as represented by the Secretary, Department of...
    • Peter Collins
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    PIV5 as an oncolytic agent
    • Patent number 10,329,585
    • Issue date Jun 25, 2019
    • University of Georgia Research Foundation, Inc.
    • Biao He
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    PIV5 as oncolytic agent
    • Patent number 9,732,358
    • Issue date Aug 15, 2017
    • University of Georgia Research Foundation, Inc.
    • Biao He
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

  • Information Patent Application

    RECOMBINANT HUMAN/BOVINE PARAINFLUENZA VIRUS 3 (B/HPIV3) EXPRESSING...
    • Publication number 20240309053
    • Publication date Sep 19, 2024
    • The United States of America, as represented by the Secretary, Department of...
    • Peter Collins
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    PIV5 AS AN ONCOLYTIC AGENT
    • Publication number 20170327845
    • Publication date Nov 16, 2017
    • University of Georgia Research Foundation, Inc.
    • Biao He
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    PARAINFLUENZA VIRUS 5 BASED VACCINES
    • Publication number 20170067080
    • Publication date Mar 9, 2017
    • University of Georgia Research Foundation, Inc.
    • Biao He
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    VACCINATION AGAINST JAPANESE ENCEPHALITIS, MEASLES, MUMPS AND RUBELLA
    • Publication number 20150273035
    • Publication date Oct 1, 2015
    • Sanofi Pasteur
    • Emmanuel Feroldi
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...